MSAM
INBP
Moloney Securities Asset Management’s INTEGRATED BIOPHARMA INC. INBP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.14K | Hold |
20,000
| – | – | ﹤0.01% | 486 |
|
|
2025
Q1 | $5.6K | Hold |
20,000
| – | – | ﹤0.01% | 475 |
|
|
2024
Q4 | $5.8K | Hold |
20,000
| – | – | ﹤0.01% | 461 |
|
|
2024
Q3 | $4.69K | Hold |
20,000
| – | – | ﹤0.01% | 474 |
|
|
2024
Q2 | $4.2K | Hold |
20,000
| – | – | ﹤0.01% | 461 |
|
|
2024
Q1 | $3.85K | Hold |
20,000
| – | – | ﹤0.01% | 448 |
|
|
2023
Q4 | $4.9K | Hold |
20,000
| – | – | ﹤0.01% | 437 |
|
|
2023
Q3 | $5.6K | Hold |
20,000
| – | – | ﹤0.01% | 417 |
|
|
2023
Q2 | $6.6K | Hold |
20,000
| – | – | ﹤0.01% | 409 |
|
|
2023
Q1 | $7.66K | Hold |
20,000
| – | – | ﹤0.01% | 415 |
|
|
2022
Q4 | $7.04K | Hold |
20,000
| – | – | ﹤0.01% | 386 |
|
|
2022
Q3 | $9K | Hold |
20,000
| – | – | ﹤0.01% | 368 |
|
|
2022
Q2 | $10K | Hold |
20,000
| – | – | ﹤0.01% | 361 |
|
|
2022
Q1 | $16K | Hold |
20,000
| – | – | ﹤0.01% | 397 |
|
|
2021
Q4 | $19K | Buy |
+20,000
| New | +$19K | ﹤0.01% | 431 |
|